Matches in SemOpenAlex for { <https://semopenalex.org/work/W2219656124> ?p ?o ?g. }
- W2219656124 endingPage "9957" @default.
- W2219656124 startingPage "9957" @default.
- W2219656124 abstract "To investigate the association of serum gamma-glutamyl transferase (GGT) levels with chronic hepatitis B infection and hepatitis B e antigen (HBeAg) seroconversion.A retrospective study was performed on clinical data collected from patients who had been positive for hepatitis B surface antigen for > 6 mo and who were antiviral-treatment naïve (n = 215) attending the Hepatitis Clinic at Nanjing Drum Tower Hospital between August 2010 and December 2013. Healthy individuals without liver disease (n = 83) were included as controls. Patients were categorized into four groups based on disease status as recommended by the European Association for the Study of the Liver: immune tolerance (IT; n = 47), HBeAg-positive hepatitis (EPH; n = 93), HBeAg-negative hepatitis (ENH; n = 20), and inactive carrier (IC; n = 55). Prediction of complete response (CR) based on serum GGT was also examined in EPH patients (n = 33) treated for 48 wk with nucleos(t)ide analogue (NA) therapy, including lamivudine plus adefovir combination therapy (n = 20) or entecavir monotherapy (n = 13). CR was defined as a serum hepatitis B virus DNA level < 500 copies/mL and HBeAg seroconversion by 48 wk of treatment.Serum GGT levels were significantly increased in EPH and ENH patients relative to the IT, IC, and healthy control groups (P < 0.01 for all). However, no significant difference in serum GGT levels was found between the EPH and ENH groups. Baseline serum GGT levels were significantly higher in patients who achieved CR (7/33; 21.2%) compared to patients in the non-CR group (26/33; 78.8%; P = 0.011). In addition, the decline in serum GGT was greater in CR patients compared to non-CR patients after 24 wk and 48 wk of treatment (P = 0.012 and P = 0.008, respectively). The receiver operating characteristic curve yielded a sensitivity of 85.71% and a specificity of 61.54% at a threshold value of 0.89 times the upper limit of normal for baseline serum GGT in the prediction of CR following NA therapy.Serum GGT is significantly elevated in EPH and ENH patients and is a potential biomarker for the prediction of HBeAg seroconversion following NA therapy." @default.
- W2219656124 created "2016-06-24" @default.
- W2219656124 creator A5001338473 @default.
- W2219656124 creator A5007774021 @default.
- W2219656124 creator A5021556335 @default.
- W2219656124 creator A5023606351 @default.
- W2219656124 creator A5039717583 @default.
- W2219656124 creator A5046174516 @default.
- W2219656124 creator A5053298239 @default.
- W2219656124 creator A5055799572 @default.
- W2219656124 creator A5072692473 @default.
- W2219656124 creator A5086289661 @default.
- W2219656124 creator A5091309807 @default.
- W2219656124 date "2015-01-01" @default.
- W2219656124 modified "2023-09-26" @default.
- W2219656124 title "Association of serum gamma-glutamyl transferase with treatment outcome in chronic hepatitis B patients" @default.
- W2219656124 cites W1840659637 @default.
- W2219656124 cites W1967163020 @default.
- W2219656124 cites W1968537378 @default.
- W2219656124 cites W1969776963 @default.
- W2219656124 cites W1982898260 @default.
- W2219656124 cites W1990320853 @default.
- W2219656124 cites W1995862451 @default.
- W2219656124 cites W2000538721 @default.
- W2219656124 cites W2001278314 @default.
- W2219656124 cites W2005015841 @default.
- W2219656124 cites W2005047152 @default.
- W2219656124 cites W2011794205 @default.
- W2219656124 cites W2012992553 @default.
- W2219656124 cites W2014666790 @default.
- W2219656124 cites W2016205218 @default.
- W2219656124 cites W2019596061 @default.
- W2219656124 cites W2031317669 @default.
- W2219656124 cites W2033557645 @default.
- W2219656124 cites W2050081098 @default.
- W2219656124 cites W2052387402 @default.
- W2219656124 cites W2056437697 @default.
- W2219656124 cites W2059560167 @default.
- W2219656124 cites W2062680879 @default.
- W2219656124 cites W2075145016 @default.
- W2219656124 cites W2080151860 @default.
- W2219656124 cites W2089252723 @default.
- W2219656124 cites W2089908069 @default.
- W2219656124 cites W2092319353 @default.
- W2219656124 cites W2095934320 @default.
- W2219656124 cites W2102864325 @default.
- W2219656124 cites W2104389844 @default.
- W2219656124 cites W2105079980 @default.
- W2219656124 cites W2110267763 @default.
- W2219656124 cites W2116047701 @default.
- W2219656124 cites W2131573378 @default.
- W2219656124 cites W2155687271 @default.
- W2219656124 cites W2167744756 @default.
- W2219656124 cites W2171771045 @default.
- W2219656124 cites W2314866596 @default.
- W2219656124 cites W238101177 @default.
- W2219656124 cites W2393327590 @default.
- W2219656124 cites W2531694387 @default.
- W2219656124 cites W4211026375 @default.
- W2219656124 doi "https://doi.org/10.3748/wjg.v21.i34.9957" @default.
- W2219656124 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4566388" @default.
- W2219656124 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26379400" @default.
- W2219656124 hasPublicationYear "2015" @default.
- W2219656124 type Work @default.
- W2219656124 sameAs 2219656124 @default.
- W2219656124 citedByCount "10" @default.
- W2219656124 countsByYear W22196561242017 @default.
- W2219656124 countsByYear W22196561242018 @default.
- W2219656124 countsByYear W22196561242019 @default.
- W2219656124 countsByYear W22196561242020 @default.
- W2219656124 countsByYear W22196561242021 @default.
- W2219656124 countsByYear W22196561242022 @default.
- W2219656124 countsByYear W22196561242023 @default.
- W2219656124 crossrefType "journal-article" @default.
- W2219656124 hasAuthorship W2219656124A5001338473 @default.
- W2219656124 hasAuthorship W2219656124A5007774021 @default.
- W2219656124 hasAuthorship W2219656124A5021556335 @default.
- W2219656124 hasAuthorship W2219656124A5023606351 @default.
- W2219656124 hasAuthorship W2219656124A5039717583 @default.
- W2219656124 hasAuthorship W2219656124A5046174516 @default.
- W2219656124 hasAuthorship W2219656124A5053298239 @default.
- W2219656124 hasAuthorship W2219656124A5055799572 @default.
- W2219656124 hasAuthorship W2219656124A5072692473 @default.
- W2219656124 hasAuthorship W2219656124A5086289661 @default.
- W2219656124 hasAuthorship W2219656124A5091309807 @default.
- W2219656124 hasBestOaLocation W22196561241 @default.
- W2219656124 hasConcept C126322002 @default.
- W2219656124 hasConcept C159654299 @default.
- W2219656124 hasConcept C203014093 @default.
- W2219656124 hasConcept C2522874641 @default.
- W2219656124 hasConcept C2775940106 @default.
- W2219656124 hasConcept C2776175608 @default.
- W2219656124 hasConcept C2777075537 @default.
- W2219656124 hasConcept C2777382497 @default.
- W2219656124 hasConcept C2777410769 @default.
- W2219656124 hasConcept C2777451964 @default.
- W2219656124 hasConcept C2777869810 @default.
- W2219656124 hasConcept C2779517838 @default.